NivolumabBullous pemphigoid: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1698卷 / 1期

关键词：

D O I：

10.1007/s40278-018-45202-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[41] Penpulimab/sintilimab/toripalimabBullous pemphigoid: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 413 - 414
[42] Nivolumab/pembrolizumabBullous pemphigoid and bullous eruption: 3 case reports
Reactions Weekly, 2017, 1673 (1) : 282 - 282
[43] VildagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2012, 1394 (1) : 41 - 41
[44] LinagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1591 (1) : 115 - 115
[45] VildagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2018, 1723 (1) : 294 - 294
[46] TozinameranBullous pemphigoid: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 406 - 406
[47] NemolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2024, 2029 (1) : 507 - 507
[48] LinagliptinBullous pemphigoid: 2 case reports
Reactions Weekly, 2021, 1872 (1) : 286 - 286
[49] AntihyperglycaemicsBullous pemphigoid: 9 case reports
Reactions Weekly, 2018, 1694 (1) : 34 - 34
[50] AntihyperglycaemicsBullous pemphigoid: 12 case reports
Reactions Weekly, 2018, 1710 (1) : 36 - 36

← 1 2 3 4 5 →